• Bone Health
  • Immunology
  • Hematology
  • Respiratory
  • Dermatology
  • Diabetes
  • Gastroenterology
  • Neurology
  • Oncology
  • Ophthalmology
  • Rare Disease
  • Rheumatology

The Top 5 Biosimilar Articles for the Week of July 29

News
Video

Here are the top 5 biosimilar articles for the week of July 29, 2024.

Number 5: Boehringer Ingelheim (BI) partners with GoodRx to offer its unbranded adalimumab biosimilar to patients at an exclusive low price; a new ustekinumab biosimilar launches in Europe; and Mexican officials approve a bevacizumab biosimilar.

Number 4: The FDA's new policy on glycan profiling of monoclonal antibodies (Mabs) receives praise and recommendations from Sarfaraz K. Niazi, PhD.

Number 3: A biosimilar dulaglutide showed similar pharmacokinetic and safety profiles compared with the reference product Trulicity in healthy Chinese participants, according to a phase 1 analysis.

Number 2: The FDA approved Epysqli (eculizumab-aagh), a biosimilar developed by Samsung Bioepis that references Soliris (eculizumab), for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).1

Number 1: Projected savings from biosimilar natalizumab were $452,611 over 3 years, driven by decreased drug acquisition costs and a utilization shift from reference to biosimilar natalizumab.

To read all of these articles and more, visit centerforbiosimilars.com.

Recent Videos
Here are the top 5 biosimilar articles for the week of December 9, 2024.
Here are the top 5 biosimilar articles for the week of December 2, 2024.
Here are the top 5 biosimilar articles for the week of November 25, 2024.
Here are the top 5 biosimilar articles for the week of November 18, 2024.
The Top 5 Biosimilar Articles of the Week.
Here are the top 5 biosimilar articles for the week of October 21, 2024.
Here are the top 5 biosimilar articles for the week of October 14, 2024.
Here are the top 5 biosimilar articles for the week of October 7, 2024.
Here are the top 5 biosimilar articles for the week of September 30, 2024.
Here are the top 5 biosimilar articles for the week of September 23, 2024.
© 2024 MJH Life Sciences

All rights reserved.